Literature DB >> 20736915

A reverse genetic approach to test functional redundancy during embryogenesis.

Amir Rikin1, Gabriel E Rosenfeld, Kellie McCartin, Todd Evans.   

Abstract

Gene function during embryogenesis is typically defined by loss-of-function experiments, for example by targeted mutagenesis (knockout) in the mouse. In the zebrafish model, effective reverse genetic techniques have been developed using microinjection of gene-specific antisense morpholinos. Morpholinos target an mRNA through specific base-pairing and block gene function transiently by inhibiting translation or splicing for several days during embryogenesis (knockdown). However, in vertebrates such as mouse or zebrafish, some gene functions can be obscured by these approaches due to the presence of another gene that compensates for the loss. This is especially true for gene families containing sister genes that are co-expressed in the same developing tissues. In zebrafish, functional compensation can be tested in a relatively high-throughput manner, by co-injection of morpholinos that target knockdown of both genes simultaneously. Likewise, using morpholinos, a genetic interaction between any two genes can be demonstrated by knockdown of both genes together at sub-threshold levels. For example, morpholinos can be titrated such that neither individual knockdown generates a phenotype. If, under these conditions, co-injection of both morpholinos causes a phenotype, a genetic interaction is shown. Here we demonstrate how to show functional redundancy in the context of two related GATA transcription factors. GATA factors are essential for specification of cardiac progenitors, but this is revealed only by the loss of both Gata5 and Gata6. We show how to carry out microinjection experiments, validate the morpholinos, and evaluate the compensated phenotype for cardiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736915      PMCID: PMC3156006          DOI: 10.3791/2020

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

Review 1.  GATA factors in Drosophila heart and blood cell development.

Authors:  Richard Paul Sorrentino; Kathleen M Gajewski; Robert A Schulz
Journal:  Semin Cell Dev Biol       Date:  2005-02       Impact factor: 7.727

Review 2.  Using the zebrafish model to study GATA transcription factors.

Authors:  Alice Heicklen-Klein; Lisa J McReynolds; Todd Evans
Journal:  Semin Cell Dev Biol       Date:  2004-12-10       Impact factor: 7.727

3.  Gata4 regulates the formation of multiple organs.

Authors:  Audrey Holtzinger; Todd Evans
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

4.  Gata5 and Gata6 are functionally redundant in zebrafish for specification of cardiomyocytes.

Authors:  Audrey Holtzinger; Todd Evans
Journal:  Dev Biol       Date:  2007-09-22       Impact factor: 3.582

Review 5.  A primer for morpholino use in zebrafish.

Authors:  Brent R Bill; Andrew M Petzold; Karl J Clark; Lisa A Schimmenti; Stephen C Ekker
Journal:  Zebrafish       Date:  2009-03       Impact factor: 1.985

6.  Redundancy and evolution of GATA factor requirements in development of the myocardium.

Authors:  Tessa Peterkin; Abigail Gibson; Roger Patient
Journal:  Dev Biol       Date:  2007-08-16       Impact factor: 3.582

  6 in total
  3 in total

1.  Investigation of Islet2a function in zebrafish embryos: Mutants and morphants differ in morphologic phenotypes and gene expression.

Authors:  Rosa L Moreno; Kristina Williams; Kenneth L Jones; Angeles B Ribera
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

2.  Zebrafish models for ectopic mineralization disorders: practical issues from morpholino design to post-injection observations.

Authors:  Mohammad Jakir Hosen; Olivier M Vanakker; Andy Willaert; Ann Huysseune; Paul Coucke; Anne De Paepe
Journal:  Front Genet       Date:  2013-05-08       Impact factor: 4.599

3.  Micromanipulation of gene expression in the adult zebrafish brain using cerebroventricular microinjection of morpholino oligonucleotides.

Authors:  Caghan Kizil; Anne Iltzsche; Jan Kaslin; Michael Brand
Journal:  J Vis Exp       Date:  2013-05-23       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.